# ATORVASTATIN CALCIUM

NDC: 50228-452
Generic name: ATORVASTATIN CALCIUM
Labeler / Manufacturer: ScieGen Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20160519

FDA application: ANDA205519

## Active ingredients

- ATORVASTATIN CALCIUM TRIHYDRATE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50228-452"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50228-452
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2d8b5e9-6ff2-4efa-ab01-e13df29f7371